B. Nicholson

Paclitaxel, 5-fluorouracil, and leucovorin (TFL) in the treatment of metastatic breast cancer.

Y. Shyr, D. Johnson, K. Hande, 2000, Clinical breast cancer.

Paclitaxel/5-fluorouracil/leucovorin in metastatic breast cancer: a Vanderbilt Cancer Center phase II trial.

Y. Shyr, D. Johnson, K. Hande, 1997, Seminars in oncology.

Docetaxel combined with trastuzumab is an active regimen in HER-2 3+ overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trial.

Yu Shyr, William J. Gradishar, G. Sledge, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Paclitaxel, UFT, and calcium folinate in metastatic breast cancer.

C. Blanke, K. Hande, N. Dickson, 1999, Oncology.

A pilot study of neoadjuvant paclitaxel and radiation with correlative molecular studies in stage II/III breast cancer.

J. Pietenpol, A. Chakravarthy, M. Kelley, 2000, Clinical breast cancer.